Aily Labs GmbH, developer of the first AI-native Decision Intelligence App for global enterprises, has announced the appointment of prominent enterprise leaders to its Board and Advisory Board. Amy Chang joins both the Board of Directors and Advisory Board, while Joseph Jimenez and Derica Rice join the Advisory Board. These strategic additions come as Aily Labs scales globally, leveraging agentic AI to transform enterprise decision-making from data observation to autonomous, personalized actions.
Scaling the Future of Decision Intelligence
1. AI-First Platform for Global Enterprises
- Aily Labs is pioneering always-on, agentic AI that powers real-time, personalized insights.
- The platform enables forward-looking decisions across corporate functions including finance, operations, and supply chain.
2. Global Expansion Backed by Visionary Leaders
- The appointments mark a pivotal moment as Aily Labs grows its footprint in the enterprise AI market.
- Focused on Fortune 500 companies, the platform is positioned to redefine how decisions are made and executed at scale.
3. Enabling Autonomy Through Agentic AI
- Aily Labs’ autonomous AI agents deliver contextual, actionable recommendations to leadership teams.
- Integrates with enterprise systems with single-day deployment, enabling instant productivity.
Amy Chang Joins Aily Labs’ Board and Advisory Board
1. Strategic Expertise and Innovation at Scale
- Chang brings board experience from Disney, P&G, Cisco, Splunk, and more — totaling nearly $1T in market cap.
- As former CEO of Accompany (acquired by Cisco), she is a veteran in digital transformation and product strategy.
2. Championing the Future of AI-Driven Work
“Aily Labs’ vision to shift enterprises from passive data to active, agent-driven action is bold,” said Chang.
“I’m thrilled to help shape the future of work through agentic AI.”
Joseph Jimenez Brings Leadership Across Healthcare and Industry
1. High-Stakes Decision-Making Experience
- Former CEO of Novartis and current Board member at GM and P&G.
- Co-Founder of Aditum Bio, with deep insights in capital allocation and precision-led strategies.
2. Aligning AI Speed with Enterprise Urgency
“In pharma, speed and precision save lives. Aily Labs applies that same urgency to enterprise leadership,” said Jimenez.
“This is the AI platform every leadership team needs.”
Derica Rice Adds Financial and Operational Depth
1. Transformational Experience in Finance and Healthcare
- Former CFO of Eli Lilly and President of CVS Caremark.
- Board member at Disney, Bristol Myers Squibb, and Carlyle Group.
2. Driving AI-Enabled Efficiency and Precision
“Aily Labs empowers people and AI agents to work seamlessly, eliminate inefficiencies, and act with precision,” said Rice.
“This is a turning point for enterprise productivity.”
With the addition of Amy Chang, Joseph Jimenez, and Derica Rice, Aily Labs strengthens its leadership bench as it pioneers the next evolution of enterprise decision-making. By combining deep industry experience with an agentic AI platform, Aily Labs is helping global organizations move from static data analysis to dynamic, AI-driven decisions that shape competitive advantage. This marks a major milestone not just for the company, but for the broader future of AI-powered enterprise leadership.
